Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio: 2021-2024

Historic FCF Payout Ratio for Ani Pharmaceuticals (ANIP) over the last 4 years, with Dec 2024 value amounting to 0.03.

  • Ani Pharmaceuticals' FCF Payout Ratio fell 82.89% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 52.58%. This contributed to the annual value of 0.03 for FY2024, which is 130.41% up from last year.
  • Per Ani Pharmaceuticals' latest filing, its FCF Payout Ratio stood at 0.03 for FY2024, which was up 130.41% from 0.01 recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' FCF Payout Ratio peaked at 0.25 during FY2021, and registered a low of -0.04 during FY2022.
  • Moreover, its 3-year median value for FCF Payout Ratio was 0.01 (2023), whereas its average is 0.00.
  • In the last 5 years, Ani Pharmaceuticals' FCF Payout Ratio crashed by 116.32% in 2022 and then surged by 136.41% in 2023.
  • Ani Pharmaceuticals' FCF Payout Ratio (Yearly) stood at 0.25 in 2021, then crashed by 116.32% to -0.04 in 2022, then spiked by 136.41% to 0.01 in 2023, then soared by 130.41% to 0.03 in 2024.